Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 20:10:1012136.
doi: 10.3389/fped.2022.1012136. eCollection 2022.

Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia

Affiliations

Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia

Rachel T Sullivan et al. Front Pediatr. .

Abstract

Left atrial hypertension (LAH) may contribute to pulmonary hypertension (PH) in premature infants with bronchopulmonary dysplasia (BPD). Primary causes of LAH in infants with BPD include left ventricular diastolic dysfunction or hemodynamically significant left to right shunt. The incidence of LAH, which is definitively diagnosed by cardiac catheterization, and its contribution to PH is unknown in patients with BPD-PH. We report the prevalence of LAH in an institutional cohort with BPD-PH with careful examination of hemodynamic contributors and impact on patient outcomes. This single-center, retrospective cohort study examined children <2 years of age with BPD-PH who underwent cardiac catheterization at Lucile Packard Children's Hospital Stanford. Patients with unrepaired simple shunt congenital heart disease (CHD) and pulmonary vein stenosis (only 1 or 2 vessel disease) were included. Patients with complex CHD were excluded. From April 2010 to December 2021, 34 patients with BPD-PH underwent cardiac catheterization. We define LAH as pulmonary capillary wedge pressure (PCWP) or left atrial pressure (LAP) of at least 10 mmHg. In this cohort, median PCWP was 8 mmHg, with LAH present in 32% (n = 11) of the total cohort. A majority (88%, n = 30) of the cohort had severe BPD. Most patients had some form of underlying CHD and/or pulmonary vein stenosis: 62% (n = 21) with an atrial septal defect or patent foramen ovale, 62% (n = 21) with patent ductus arteriosus, 12% (n = 4) with ventricular septal defect, and 12% (n = 4) with pulmonary vein stenosis. Using an unadjusted logistic regression model, baseline requirement for positive pressure ventilation at time of cardiac catheterization was associated with increased risk for LAH (odds ratio 8.44, 95% CI 1.46-48.85, p = 0.02). Small for gestational age birthweight, sildenafil use, and CHD were not associated with increased risk for LAH. LAH was associated with increased risk for the composite outcome of tracheostomy and/or death, with a hazard ratio of 6.32 (95% CI 1.72, 22.96; p = 0.005). While the etiology of BPD-PH is multifactorial, LAH is associated with PH in some cases and may play a role in clinical management and patient outcomes.

Keywords: bronchopulmonary dysplasia (BPD); diastolic dysfunction; left atrial hypertension; prematurity; pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Forest plot of risk factors for left atrial hypertension: Risk for left atrial hypertension for select clinical factors is demonstrated in this Forest plot, along with associated odds ratio and p-value. Positive pressure ventilation (PPV) was the only variable that demonstrated significant risk for left atrial hypertension. SGA, small for gestational age; PPV, positive pressure ventilation; CHD, congenital heart disease; PDA, patent ductus arteriosus.
Figure 2
Figure 2
Hemodynamic changes with acute vasodilator testing. Changes in mean pulmonary artery pressure, left atrial pressure, and pulmonary vascular resistance are demonstrated at baseline and with maximal vasodilation (100% FiO2 ± inhaled nitric oxide) utilized in acute vasodilator testing, which was performed in 16 patients.

References

    1. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. (2019) 53:1801913. 10.1183/13993003.01913-2018 - DOI - PMC - PubMed
    1. Arjaans S, Zwart EAH, Ploegstra M, Bos AF, Kooi EMW, Hillege HL, et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. (2018) 32:258–67. 10.1111/ppe.12444 - DOI - PubMed
    1. Kim D-H, Kim H-S, Choi CW, Kim E-K, Kim BI, Choi J-H. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology. (2012) 101:40–6. 10.1159/000327891 - DOI - PubMed
    1. Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. (2012) 129:e682–9. 10.1542/peds.2011-1827 - DOI - PMC - PubMed
    1. Mourani PM, Abman SH. Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol. (2015) 42:839–55. 10.1016/j.clp.2015.08.010 - DOI - PMC - PubMed